Alpine Global Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Alpine Global Management’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-25,000	Closed	-$1.31M	–	371
2020 Q3	$1.31M	Buy	+25,000	New	+$1.03M	0.27%	54

Alpine Global Management's MNTA Position: Q4 2020 in Review

Alpine Global Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 25,000 shares — an estimated $1.31M sold.

Alpine Global Management first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $1.31M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Alpine Global Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Alpine Global Management sold 25,000 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $1.31M.
Alpine Global Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
Alpine Global Management's Momenta Pharmaceuticals, Inc. position peaked at $1.31M in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Alpine Global Management's 13F filing for Q4 2020, filed 12 Feb 2021.